|
C12ORF41 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.48209999997862E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.799510E-04 |
| Normal-vs-Stage2 |
6.340300E-02 |
| Normal-vs-Stage3 |
3.630500E-02 |
| Normal-vs-Stage4 |
7.378100E-02 |
| Stage1-vs-Stage2 |
9.326600E-01 |
| Stage1-vs-Stage3 |
9.162400E-01 |
| Stage1-vs-Stage4 |
3.338800E-01 |
| Stage2-vs-Stage3 |
8.915600E-01 |
| Stage2-vs-Stage4 |
2.702400E-01 |
| Stage3-vs-Stage4 |
3.043600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.95930000000044E-05 |
| Normal-vs-AfricanAmerican |
2.597900E-04 |
| Normal-vs-Asian |
9.613700E-02 |
| Caucasian-vs-AfricanAmerican |
2.216400E-01 |
| Caucasian-vs-Asian |
2.711400E-01 |
| AfricanAmerican-vs-Asian |
6.671200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.89510000003779E-06 |
| Normal-vs-Female |
2.038600E-03 |
| Male-vs-Female |
3.131600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.562000E-03 |
| Normal-vs-Extreme_Weight |
8.357100E-04 |
| Normal-vs-Obese |
1.595690E-03 |
| Normal-vs-Extreme_Obese |
5.275200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.520200E-01 |
| Normal_Weight-vs-Obese |
6.863600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.751400E-01 |
| Extreme_Weight-vs-Obese |
9.178800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.231000E-01 |
| Obese-vs-Extreme_Obese |
3.086600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.537100E-03 |
| Normal-vs-Age(41-60Yrs) |
5.6292999994767E-07 |
| Normal-vs-Age(61-80Yrs) |
1.601980E-03 |
| Normal-vs-Age(81-100Yrs) |
5.222400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.156400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.982100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.132020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.353500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.729200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.066600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.31129995750712E-09 |
| Normal-VS-Type2 PRCC |
7.724800E-01 |
| Normal-VS-KIRP CIMP |
2.978800E-01 |
| Normal-VS-Unclassified PRCC |
1.200450E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.34510000027177E-07 |
| Type1 PRCC-VS-KIRP CIMP |
3.033000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.701010E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.946750E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.386210E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.335200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.546000E-02 |
| Normal-vs-N1 |
8.343000E-03 |
| Normal-vs-N2 |
9.664000E-01 |
| N0-vs-N1 |
1.795770E-01 |
| N0-vs-N2 |
4.746200E-01 |
| N1-vs-N2 |
2.352400E-01 |
|
|
